Page Nct des essais cliniques
Clinical Trial Results:
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of licarbazepine 750-2500 mg/d combined with risperidone in the treatment of manic episodes of bipolar I disorder over 6 weeks
| Summary | |
EudraCT number | 2004-000113-18 |
Trial protocol | ES HU FI |
Global completion date | 04 Apr 2007 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 09 Oct 2016 |
First version publication date | 09 Oct 2016 |
Other versions | |
Summary report(s) | CLIC477D2302_NovCTR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.